Last reviewed · How we verify

NCT03886883

Endogenous Modulation of Pain and Stretch Tolerance

Completed NA Last updated 26 March 2019
What this trial tests

NA trial testing Exercise induced hypoalgesia (EIH) in Pain Threshold in 19 participants. Completed in 30 December 2017.

Timeline
1 October 2017
Primary endpoint
30 December 2017
30 December 2017

Quick facts

Lead sponsorUniversity College of Northern Denmark
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment19
Start date1 October 2017
Primary completion30 December 2017
Estimated completion30 December 2017
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University College of Northern Denmark

Who can join

Adults 18 to 45, male only, with Pain Threshold. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the role of two endogenous inhibitory mechanisms; exercise-induced hypoalgesia (EIH) and a conditioning painful stimulus (CPM) on passive joint range of motion, passive resistive torque and pain sensitivity. The study is a randomized, repeated-measures cross-over study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain Threshold

Currently open trials in the same condition.

Other University College of Northern Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03886883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing